RxDoctor Payments Data

Daniel Vanhimbergen, MD

Otolaryngology · Richmond, VANPI 1639354459

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.7% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Aerin Medical Inc. at 26.6% of the total.

$4,211in general payments, 2019–2025

Across 110 payments — averaging $38.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • GSK$656
  • Medtronic$451
  • Sanofi$291
  • Intersect ENT, Inc.$166
  • plus $458 from 9 others

What the payments were for

  • Food & beverage$4,11298%
  • Education$982%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,211 in reported general payments places this provider in the 80th percentile of 241 otolaryngology providers in Virginia.

See all otolaryngology providers in Virginia

Medicare billing

Part B allowed, 2024
$165,765
Medicare patients
651
Services billed
1,431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide150$4,685
Mometasone Furoate23$2,229
Azelastine Hcl57$2,026
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,895
Fluticasone Propionate129$1,651
Ofloxacin69$1,137
Fluocinolone Acetonide20$803
Prednisone67$643
Cefdinir24$482
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav49$406
Mupirocin13$399
Omeprazole54$357
Doxycycline Monohydrate20$226
Nortriptyline Hcl28$180
Pantoprazole Sodium24$148

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →